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Abstract
Background: The World Health Organization’s Global Burden of Disease (GBD) reports are an important tool for global
health policy makers, however the accuracy of estimates for countries undergoing an epidemiologic transition is unclear.
We attempted to validate the life table model used to generate estimates for all-cause mortality in developing countries.
Methods and Results: Data were obtained for males and females from the Human Mortality Database for all countries with
available data every ten years from 1900 to 2000. These provided inputs for the GBD life table model and served as
comparison observed data. Above age sixty model estimates of survival for both sexes differed substantially from those
observed. Prior to the year 1960 for males and 1930 for females, estimated survival tended to be greater than observed;
following 1960 for both males and females estimated survival tended to be less than observed. Viewing observed and
estimated survival separately, observed survival past sixty increased over the years considered. For males, the increase was
from a mean (sd) probability of 0.22 (0.06) to 0.46 (0.1). For females, the increase was from 0.26 (0.06) to 0.65 (0.08). By
contrast, estimated survival past sixty decreased over the same period. Among males, estimated survival probability
declined from 0.54 (0.2) to 0.09 (0.06). Among females, the decline was from 0.36 (0.12) to 0.15 (0.08).
Conclusions: These results show that the GBD mortality model did not accurately estimate survival at older ages as
developed countries transitioned in the twentieth century and may be similarly flawed in developing countries now
undergoing transition. Estimates of the size of older-age populations and their attributable disease burden should be
reconsidered.
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Introduction
Estimating the mortality and morbidity burden of diseases
worldwide is an important part of setting meaningful global health
priorities. Since the 1990s, Global Burden of Disease (GBD) series
of reports estimate rates of mortality and morbidity for countries
that lack systems of vital registration or disease registries. These
reports [1–3] and related papers [4,5], which are currently
produced by the World Health Organization, are frequently
referenced and cited by governments and NGOs when setting
their priorities for funding in health.
It is straightforward to produce estimates for the numbers of
deaths by cause for countries that maintain vital registration
systems with complete, national coverage. For many developing
countries, which lack such systems, the process requires mathe-
matical modeling to generate estimates. For the GBD reports, a
two-step process was used: first, a ‘‘mortality envelope’’ of deaths
by age and sex was estimated using a demographic model [6] to
produce mortality rates and United Nations population data to
estimate numbers of deaths. A second model then estimated the
proportion of deaths by cause by age for each sex [7]. This process
was required for 92 out of 192 WHO member states in the last full
report, published in 2006 [2].
Of concern in these models is their development and validation
using data primarily from developed countries, despite being
intended for estimation of mortality in developing countries.
Complicating this and potentially limiting options for straightfor-
ward correction is the epidemiologic transition. This is the
phenomena in which countries, as they develop socially and
economically, move toward lower, if still significant, burdens of
communicable disease and perinatal mortality and greater
burdens of non-communicable chronic diseases (NCDs). While
the nature of the transition is well-described among now-
developed countries, it is unclear if their experience of transition,
which occurred at higher levels of economic development and at a
slower pace, can represent that of developing countries today.
If data were available from suitable sources, the GBD model
could be validated for the very populations in the developing world
where its model estimates have their greatest application. Since
such data are not available, we chose instead to test the model’s
performance for countries in the developed world with reliable
data as they underwent transition over the course of the 20
th
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a database of vital registration data on mortality for developed
countries would illustrate performance characteristics of the model
and suggest potential limitations in application to developing
countries currently transitioning.
Methods
The life table is a tool in demography that describes the
mortality experience of a synthetic population comprised of a
series of cross-sectional groups of individuals. Thus, rather than
following a cohort of people through time to measure their
survival, the life table presents current mortality rates in each age
group and across both sexes in an existing population. While this
approach presents a generic limitation to the use of life tables as
predictive tools, they are invaluable for understanding current
mortality in a given population. Life tables can be used to produce
hypothetical estimates, such as life expectancy and survival
probabilities. In calculating survival probabilities, one asks what
fraction of individuals of a given age would survive to a certain
later age if existing mortality rates did not change. Life expectancy
asks what mean survival would be for children born that year if
current mortality rates remained constant over their lifetime.
Conversely, the survival probabilities could be used to estimate the
total number of deaths across all age groups in a given population,
as is done in the GBD series.
For developing countries, a model life table was developed and
used by the GBD authors. This model is a modified Brass logit life
table system, which is described fully elsewhere [6]. Briefly, the
Brass logit life table system treats life tables as linear transforma-
tions of a standard life table. A contribution of the GBD authors
was to make this system more robust in situations where the
relationship between the estimated and standard life tables is not
linear. Their extension was developed using 1,802 life tables from
the 20
th century, predominantly from European, North American,
and Australasian countries. The formulae they used for estimating
life tables are shown in Text S1.
The model life table used in the GBD requires inputs of survival
from birth to ages five and sixty. For 55 of the 92 countries that
required model estimation of all-cause mortality, only UNICEF
estimates for child survival to age five were available. These
estimates were linked to survival to age sixty using regression
techniques in order to produce survival data to ages 5 and 60 for
the demographic model [8]; we do not assess this model in this
paper. In the remaining 37 countries, available data, including
surveys and incomplete vital registration data, were used to
produce model inputs. These processes are outlined in Figure 1.
This GBD model life table uses the available data to estimate
mortality up to age 85. During the development of the GBD
model, the investigators validated its performance using standard
techniques of split sample evaluation, separating the sample into
training and test sets. These assessments confirmed the internal
validity of the model. However, validation against an external
population has not been published.
To assess the performance of the GBD, we used data from the
Human Mortality Database (HMD) [9]. This database contains
life tables for 37 countries dating back as far as the year 1751. For
this study, we obtained ‘‘observed’’ mortality rates by using life
tables for males and females for the first year of every decade
beginning with 1900 for all 37 countries. For those countries
where data were not available in 1900, the first year of a decade
with available data was used. The Federal Republic of Germany,
the German Democratic Republic, and re-unified Germany were
treated separately. Scotland was analyzed separately from England
and Wales and Northern Ireland was not analyzed. For France
and New Zealand, national populations were used.
These life tables also provided the inputs—survival from birth to
ages 5 and 60– for the above formulae to construct ‘‘estimated’’
life tables using the GBD model. Data were analyzed using R
version 2.10.0 [10].
Results
We first evaluated the ratio of estimated to observed survival for
ages fifteen to sixty from 1900 to 2000 for all countries for all
years. As expected, the GBD model ‘‘estimates’’ of survival closely
matched the observed survival rates (data not shown). We further
explored error between ages fifteen and sixty and found some
underestimation of mortality rates, however this was small and did
not vary in magnitude over time (data not shown). It can be shown
Figure 1. This figure outlines methods used in the GBD for estimating mortality in countries without complete vital registration
data. A shows the GBD model for arriving at mortality estimates for countries with only UNICEF child mortality estimates. B shows this process for
countries that have mortality data that are not from vital registries.
doi:10.1371/journal.pone.0020264.g001
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to the input observed survival from birth to age five, and thus it
was not evaluated.
Box plots showing the ratio of estimated to observed survival
rates from age 60 to age 80 (20l60) from 1900 to 2000 are
displayed in Figure 2; the year of the data is given along the x-
axis and the ratio of the model-estimated to HMD-observed
survival probability is given along the y-axis. As this figure shows,
the GBD model substantially over-estimates survival probabilities
among males in the first half of the 20
th century, whereas for
Figure 2. This figure shows box-and-whisker plots of the ratio of GBD model estimated survival from age 60 to 80 to the observed
survival for each year in the set of life tables for males (top) and females (bottom).
doi:10.1371/journal.pone.0020264.g002
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the century, the model overestimates mortality for both males
and females, with ever increasing deviation from observed
mortality over time.
To decompose these findings, plots of estimated and observed
20l60 were produced separately for males and females (Figures 3
and 4). These figures show that for both sexes, actual or observed
survival probabilities have been increasing with time. For males,
Figure 3. This figure shows observed survival from age 60 to age 80 for males from 1900 to 2000 (top) and the estimated survival
for males in the same period (bottom).
doi:10.1371/journal.pone.0020264.g003
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0.46 (0.1). For females, the increase was from 0.26 (0.06) to 0.65
(0.08).
By contrast, survival probabilities estimated from the GBD
model have been decreasing over the same period of time Among
males, estimated survival probability declined from 0.54 (0.2) to
Figure 4. This figure shows observed survival from age 60 to age 80 for females from 1900 to 2000 (top) and the estimated survival
for females in the same period (bottom).
doi:10.1371/journal.pone.0020264.g004
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0.15 (0.08).
Discussion
Our results demonstrate that, through time measured from the
beginning of the 20
th century to the beginning of the 21
st, the GBD
model life table systematically misestimates survival from age sixty
to age eighty in a sample of countries that experienced substantial
economic (and other) development over that period. Before 1960,
the GBD model tends to overestimate survival; after 1960, it tends
to underestimate survival. This impairment in model performance
holds true across the diversity of countries in the sample, which
includes both Western and Soviet Bloc countries, European and
Asian populations, and countries that, for at least a portion of the
years sampled, were considered developing countries. Further, the
model estimates a trend of increasing mortality at older ages
through time, whereas the observed trend is of declining mortality
at these ages.
These findings contradict the conclusions of the validation
attempted by the model’s developers [7]. In the paper describing
this model, they used a sample of 1,802 life tables, roughly 1,000 of
which were from Western countries, Japan, and Singapore
between 1950 and 1998. Even with life tables from the countries
and years included in the model, however, it does not accurately
estimate survival at older ages except for the year 1960. This is
approximately the weighted average of the years represented
among 1,802 life tables.
This suggests that the model treats countries as facing a
relatively static mortality pattern, specifically that of the middle of
the 20
th century. This is likely to be inaccurate for countries
transitioning today, as it was for describing the developed
countries in our sample as they transitioned.
The findings reported in this paper also call into question the
mortality estimates at older ages presented in the GBD reports,
particularly in light of the assertion in the update published in
2008 that half of global mortality occurs after age sixty. Our data
and analysis suggests that mortality at these older ages in
developing countries is being over- or under-estimated, possibly
substantially. Given the rapid increases in life expectancy
worldwide, with the possible exception of Sub-Saharan Africa,
the concern for over-estimation among the 92 countries where this
model was applied would appear far more likely.
Our study was not designed to identify the specific reasons for
the GBD model’s poor performance. Our analysis does illustrate
an important general conclusion that has far-reaching policy
implications. When Western countries were experiencing the
economic transitions that developing countries are experiencing
now, the proportion of the population at older ages in Western
nations was likely much lower. The GBD model fails to accurately
estimate the growing number of older persons in developing
countries at the very time when their economic resources are
already strained and as they attempt to meet the healthcare needs
of their populations.
An additional limitation to this study, which strongly suggesting
there is substantial error in GBD estimates, is that we cannot
quantify that error. In particular, we are unable to specify to what
extent the model under- or over-estimates survival from age sixty
to age eighty. If one believes that contemporary developing
countries as a whole closely resemble developed countries in 1960
one may even argue that there is little error in this estimate,
however their diversity as a group and the rapidity of their
individual epidemiologic transitions make this unlikely.
Current estimates of older-age mortality in the GBD reports
that are not derived from count-based data should not be accepted
as valid uncritically nor as representing the actual mortality
experience of those in the population over the age of sixty. Further
work to improve models based to the fullest extent possible on
inferences from observations in low/middle income countries,
however imperfect, will be necessary to restore confidence in the
mortality estimates derived from the GBD model and to ensure
appropriate allocation of resources for global health.
Supporting Information
Text S1 Briefly outlines the formulae used in the GBD model life
table.
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